Skip to content

Lunaphore COMET

Sirona Dx is the first CRO in North America to provide access to the COMET™ platform from Lunaphore.

Our industry leading spatial biology service suite now includes the COMET™ platform to perform hyperplex assays based on flexible and fully automated sequential immunofluorescence (seqIF™) to develop custom panels.

Capabilities

  • Throughput – high capacity (4 slides) and rapid turnaround time (40 minutes every two markers) provide unmatched hyperplex throughput.
  • Fast assay development: panels can be developed in weeks rather than months. Panels are optimized by characterizing simple modules of 1-2 markers. Once characterized, markers can be shuffled in any protocol cycle or added to any new panel without any further optimization. Batch optimization possible (Figure 2).
  • Hyperplex: automated 40-plex runs detected on the same tissue slide.
  • Reproducibility – full automation, use of standard primary antibodies without the need of complex upstream conjugation and direct detection via secondary antibodies, eliminate downstream complexity and variability leading to high reproducibility.
  • Quality – highly controlled staining conditions thanks to a microfluidic technology (FFeX™) deliver immunofluorescence multiplex analysis comparable to classic IHC.
  • Preserved tissue morphology – low exposure to reagents thanks to rapid incubations, and a gentle antibody removal, preserve the tissue to obtain high-quality stainings and enable downstream applications and H&E cross-validation on the same sample.
  • Off-the-shelf primary antibodies – with a reagent agnostic approach, optimize using your own clones and reagent library; no conjugation and further validation required.
  • Subcellular resolution – 230 nm resolution
  • Integrated microscope – 20X magnification, TRITC, Cy5, DAPI channels.
  • Common sample types: FFPE, FS, TMAs
  • Output OME.TIFF – file supported by most image analysis tools.

Content

Our industry leading spatial biology service suite now includes the COMET™ platform to perform hyperplex assays based on flexible and fully automated sequential immunofluorescence (seqIF™) to develop custom panels.

Capabilities

  • Throughput – high capacity (4 slides) and rapid turnaround time (40 minutes every two markers) provide unmatched hyperplex throughput.
  • Fast assay development: panels can be developed in weeks rather than months. Panels are optimized by characterizing simple modules of 1-2 markers. Once characterized, markers can be shuffled in any protocol cycle or added to any new panel without any further optimization. Batch optimization possible (Figure 2).
  • Hyperplex: automated 40-plex runs detected on the same tissue slide.
  • Reproducibility – full automation, use of standard primary antibodies without the need of complex upstream conjugation and direct detection via secondary antibodies, eliminate downstream complexity and variability leading to high reproducibility.
  • Quality – highly controlled staining conditions thanks to a microfluidic technology (FFeX™) deliver immunofluorescence multiplex analysis comparable to classic IHC.
  • Preserved tissue morphology – low exposure to reagents thanks to rapid incubations, and a gentle antibody removal, preserve the tissue to obtain high-quality stainings and enable downstream applications and H&E cross-validation on the same sample.
  • Off-the-shelf primary antibodies – with a reagent agnostic approach, optimize using your own clones and reagent library; no conjugation and further validation required.
  • Subcellular resolution – 230 nm resolution
  • Integrated microscope – 20X magnification, TRITC, Cy5, DAPI channels.
  • Common sample types: FFPE, FS, TMAs
  • Output OME.TIFF – file supported by most image analysis tools.

Content

Figure 1. Hyperplex panels can be easily developed on COMET™ with guided protocols for optimization and flexible choice of marker positioning.

Figure 3. Single-cell resolution achieved with 40-plex staining on COMET™. The left panel shows five markers detected on a TMA of lung adenocarcinoma with lymph node metastasis. The middle and right panels show a selection of regions of interest (ROIs) to identify different cell types.

Comprehensive End to End Service Includes:

  • Assay customization
  • Multiplex Assay Optimization
  • Slide Staining
  • Advanced Bioinformatics Analysis

Applications

  • Biomarker discovery and development
  • Immuno-oncology
  • Inflammatory and autoimmune diseases
  • Neuro-immunology
  • Characterization of tissue microenvironment
  • Therapeutic response
  • Drug safety and toxicity
  • Oncology

Please reach us at info@sironadx.com for more information

Contact Us

Address

4640 Southwest Macadam Avenue,
Portland, Oregon 97239

Hours

Monday – Friday: 8:00am – 6:00pm PST
Saturday – Sunday: Closed